Login
Forgot Password?
New user? Sign up here
Register
Already Registered? Sign in here
Complete Your Profile
Change Password
Request a Password Reset
Enter your email below and we will send you instructions to reset your password.
Download Documents
Tender Notice
Download
Contract Award Notice
Get Help to Participate in This Tender
Our team will contact you shortly.
Your activation form is pending.
Please submit it to start receiving email alerts.
Home » Search RFP » Latest Global Atorvastatin RFP & RFQ
Ezetimibe Plus Atorvastatin Tab, Qty: 1500 NO, (BOQ Item #134)
Deadline: 15 Oct 2025
India
TOT Reference No.: 127025090
Aspirin 75 Mg Plus Atorvastatin 10 Mg Tab, Qty: 15000 NO, (BOQ Item #25)
TOT Reference No.: 127024775
Aspirin 75 Mg Plus Atorvastatin 10 Mg Plus Clopidogril 75 Mg Tab, Qty: 15000 NO, (BOQ Item #26)
TOT Reference No.: 127024776
Atorvastatin 40 Mg Tab, Qty: 3000 NO, (BOQ Item #28)
TOT Reference No.: 127024778
Supply of Atorvastatin Tablet 20 Mg Qty 1 Nos at Shimla
Deadline: 10 Oct 2025
TOT Reference No.: 127013923
Supply of Atorvastatin Tablet 40Mg Qty 1 Nos at Shimla
TOT Reference No.: 127013894
Tab Atorvastatin 20mg, Qty: 1500 No, (BOQ Item #7)
TOT Reference No.: 127002521
Medicines for Cho Pharmacy
Deadline: 02 Oct 2025
Philippines
TOT Reference No.: 126984930
Corrigendum: Tab Ecosprin 75 mg and Atorvastatin 10 mg, Qty: 57600 No, (BOQ Item #6)
Deadline: 27 Sep 2025
TOT Reference No.: 126972094
Corrigendum: Tab Atorvastatin 40 mg, Qty: 1400 No, (BOQ Item #141)
Deadline: 30 Sep 2025
TOT Reference No.: 126968374
Deadline: {{rowDetails.Bid_Deadline_1}}
{{rowDetails.Country_Name}}
TOT Reference No.: {{rowDetails.ID}}
No Data Found..!!
AFRICA TENDERS
AMERICAS TENDERS
Browse Tenders from below Sections
Regions
Countries
geo-political
funding agencies
Sectors
Indian states
Indian cities
purchasers
Fill form below to get callback from Tender Experts.
Thanks for contacting Tendersontime. Someone from our team will contact you within 24 Hrs.
Something Went Wrong !! Please Try Again.
Click button to send your details.